Virus elimination during the recycling of chromatographic columns used during the manufacture of coagulation factors-Reference-Cited by-同舟云学术

Virus elimination during the recycling of chromatographic columns used during the manufacture of coagulation factors

Published:2014-07 Issue:4 Volume:42 Page:184-190
ISSN:1045-1056
Container-title:Biologicals
language:en
Short-container-title:Biologicals

Author:

Roberts Peter L.

Publisher

Elsevier BV

Subject

Pharmacology,General Immunology and Microbiology,Applied Microbiology and Biotechnology,General Medicine,Bioengineering,Biotechnology

Reference13 articles.

1. Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency. Guideline on plasma-derived medicinal products. EMA/CHMP/BWP/706271/2010.

2. Chromatographic removal of viruses from plasma derivatives;Burnouf;Dev Biol Stand,1993

3. Ultrapure plasma factor VIII produced by anti-F VIIIc immunoaffinity chromatography and solvent/detergent viral inactivation. Characterisation of the Method M process and Hemofil M antihemophilic factor (human);Griffith;Ann Hematol,1991

4. Large-scale preparation and biochemical charactization of a new high purity factor IX concentrate prepared by metal chelate affinity chromatography;Feldman;Blood Coagul Fibrinolysis,1994

5. Virological safety of the purified factor IX concentrate, Replenine;Roberts;Haemophilia,1995

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances in Supramolecular Affinity Separations;Advances in Chromatography;2021-10-21

2. Polysaccharide-based chromatographic adsorbents for virus purification and viral clearance;Journal of Pharmaceutical Analysis;2020-08

3. Virus Reduction of Human Plasma-Derived Biological Medicines;Jundishapur Journal of Natural Pharmaceutical Products;2017-02-28

4. Virus elimination during the purification of monoclonal antibodies by column chromatography and additional steps;Biotechnology Progress;2014-09-12